Synaptophysin identified in metastases of neuroendocrine tumors by immunocytochemistry and immunoblotting.
Synaptophysin, an Mr 38,000 integral membrane glycoprotein of neurotransmitter vesicles, has been identified in diverse primary neuroendocrine (NE) tumors of both neural and epithelial origin (Wiedenmann and co-workers, Proc Natl Acad Sci USA 1986; 83: 3500-3504). In the present study, metastases of several types of NE tumors, including medullary thyroid carcinoma, gastrinoma, insulinoma, small (oat) cell carcinoma of the lung, gastrointestinal carcinoid, and neuroblastoma, were examined for the presence of synaptophysin by immunocytochemistry, with the use of tissue sections as well as centrifuged cell suspensions and by immunoblotting of tumor proteins. The results show that expression of synaptophysin can be maintained during formation of metastases. Therefore, the authors propose that synaptophysin antibodies be used for the positive identification of metastatic NE tumors, notably in differential diagnosis. The possible implications of these findings for tumor diagnosis are discussed.
D004700:Endocrine System Diseases / Q000145:classification / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007150:Immunohistochemistry; D007158:Immunologic Techniques; D008565:Membrane Proteins / Q000378:metabolism*; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000145:classification / Q000378:metabolism; D009423:Nervous System Neoplasms / Q000145:classification / Q000378:metabolism / Q000556:secondary*; D016708:Synaptophysin
D008565:Membrane Proteins; D016708:Synaptophysin